Correlation Between Pfizer and AllovirInc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and AllovirInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and AllovirInc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and AllovirInc, you can compare the effects of market volatilities on Pfizer and AllovirInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of AllovirInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and AllovirInc.

Diversification Opportunities for Pfizer and AllovirInc

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and AllovirInc is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and AllovirInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AllovirInc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with AllovirInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AllovirInc has no effect on the direction of Pfizer i.e., Pfizer and AllovirInc go up and down completely randomly.

Pair Corralation between Pfizer and AllovirInc

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.21 times more return on investment than AllovirInc. However, Pfizer Inc is 4.79 times less risky than AllovirInc. It trades about -0.09 of its potential returns per unit of risk. AllovirInc is currently generating about -0.04 per unit of risk. If you would invest  3,729  in Pfizer Inc on January 26, 2024 and sell it today you would lose (1,102) from holding Pfizer Inc or give up 29.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  AllovirInc

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
AllovirInc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in AllovirInc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, AllovirInc may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Pfizer and AllovirInc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and AllovirInc

The main advantage of trading using opposite Pfizer and AllovirInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, AllovirInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AllovirInc will offset losses from the drop in AllovirInc's long position.
The idea behind Pfizer Inc and AllovirInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like